Hypertensive Response During Dobutamine Stress Echocardiography: Does it Indicate a Higher Risk of Developing

Hedieh Alimi1, Amirhossein Mirzaei2, Maryam Soleimani Farzaghi2

  • 1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

PubMed

Insights

Abnormal blood pressure responses during dobutamine stress echocardiography (DSE) do not predict future cardiovascular events. This study found no significant differences in adverse outcomes between patients with and without hypertensive responses during DSE.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Diagnostic Imaging

Background:

  • Abnormal blood pressure (BP) responses are a common complication of dobutamine stress echocardiography (DSE).
  • Understanding the implications of these BP responses is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between hypertensive responses during DSE and subsequent cardiovascular outcomes.
  • To determine if abnormal BP responses during DSE are predictive of adverse events.

Main Methods:

  • A cohort study comparing patients with (n=62) and without (n=55) hypertensive responses during DSE.
  • Exclusion criteria included prior hypertension and diabetes.
  • Follow-up for 4 years monitored for hypertension, myocardial infarction (MI), heart disease hospitalization, death, and stroke.

Main Results:

  • Patients with hypertensive responses during DSE had higher baseline systolic and diastolic BP and received higher dobutamine doses.
  • No statistically significant differences were found between groups in rates of death, acute MI, chronic hypertension, diabetes, or hospitalization.
  • Baseline BP and dobutamine dosage were significantly higher in the hypertensive response group.

Conclusions:

  • Hypertensive responses during DSE are not associated with increased adverse cardiovascular outcomes in patients without prior hypertension or diabetes.
  • Larger sample sizes may be needed to detect subtle differences in hypertension rates.
  • The findings suggest that abnormal BP responses during DSE may not be a significant predictor of long-term cardiovascular risk in this population.
Abstract

Related Concept Videos

Assessing Blood pressure using a doppler ultrasound01:19

Assessing Blood pressure using a doppler ultrasound

To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
2.3K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
465
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
707
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K